1. Walker R. Under fire. A history of tobacco smoking in Australia. Melbourne: Melbourne University Press; 1984.
2. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519–33. Available from: http://www.bmj.com/cgi/reprint/328/7455/1519
3. Doll R, Hill A. Smoking and carcinoma of the lung. Br Med J 1950;2:739–48.
4. Wynder E, Graham E. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. JAMA 1950;143:329–36.
5. US Department of Health and Human Services. The health consequences of smoking. A report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office of the Surgeon General; 2004. Available from: http://www.surgeongeneral.gov/library/smokingconsequences/
6. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. PHE 82. Canberra: Australian Institute for Health and Welfare; 2007. Available from: http://www.aihw.gov.au/publications/index.cfm/title/10317
7. Collins D, Lapsley H. The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004–05. P3 2625. Canberra: Department of Health and Ageing; 2008. Available from: http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/mono64/$File/mono64.pdf
8. Peto R, Lopez A, Boreham J, Thun M. Mortality from smoking in developed countries 1950–2000. Australia. Oxford: Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford; 2006. Available from: http://www.ctsu.ox.ac.uk/~tobacco/C5020.pdf
9. Ezzati M, Lopez A. Estimates of global mortality attributable to smoking in 2000. Lancet 2000;362:847–52.
10. Australian Institute of Health and Welfare, National Heart Foundation of Australia. Heart, stroke and vascular diseases—Australian facts 2004. AIHW Cat. No. CVD 27 Cardiovascular Disease Series No. 22. Canberra: AIHW and National Heart Foundation of Australia; 2004. Available from: http://www.aihw.gov.au/publications/cvd/hsvd04/hsvd04.pdf
11. Page A, Tobias M, Glover J, Wright C, Hetzel D, Fisher E. Australian and New Zealand Atlas of Avoidable Mortality. Adelaide: Public Health Information Development Unit, University of Adelaide; 2006. Available from: http://www.publichealth.gov.au/atlas_avoidable.html
12. Benowitz N. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. New Engl J Med 1988;319:1318–30.
13. US Department of Health and Human Services. The health consequences of smoking: cardiovascular disease. A report of the Surgeon General. DHHS Publication No PHS 84–50204. Rockville MD: US Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 1983. Available from: http://profiles.nlm.nih.gov/NN/B/B/T/D/segments.html
14. Bjartveit K, Tverdal A. Health consequences of smoking 1–4 cigarettes per day. Tob Control 2005;14:315–20. Available from:
http://tobaccocontrol.bmj.com/cgi/reprint/14/5/315
15. US Department of Health and Human Services. Women and smoking. A report of the US Surgeon General. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2001. Available from: http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2001/sgr_women_chapters.htm
16. Nakamura K, Barzi F, Lam TH, Huxley R, Feigin VL, Ueshima H, et al. Cigarette smoking, systolic blood pressure, and cardiovascular diseases in the Asia-Pacific region. Stroke 2008;PMID: 18323508 Stroke 2008;39:1694–702.
17. National Heart Foundation of Australia. Let's talk about heart failure. Canberra: National Heart Foundation of Australia; February 2003. Available from: http://www.heartfoundation.org.au/document/NHF/heartfailureinfosheet.pdf
18. Australian Institute of Health and Welfare AIHW, Australasian Association of Cancer Registries AACS. Cancer survival in Australia 2001. Part 1: National summary statistics. AIHW Cat. No. CAN 13 Cancer Series No 18. Canberra: AIHW; 2001. Available from: http://www.aihw.gov.au/publications/can/csa01part1/csa01part1-c03.pdf
19. Australian Institute of Health and Welfare AIHW, Australasian Association of Cancer Registries AACR. Cancer in Australia 2001. AIHW Cat. No. CAN 23 Cancer Series no. 28. Canberra: AIHW; 2004. Available from: http://www.aihw.gov.au/publications/index.cfm/title/10083
20. Collins D, Lapsley H, Canberra: Department of Health and Ageing. Personal communication. Unpublished data from research undertaken for The costs of tobacco, alcohol and illicit drug abuse to Australian society in 2004–05. Commonwealth Department of Health and Ageing, 2007. Recipient, Winstanley M, 2007.
21. US Department of Health Education and Welfare. Smoking and health: A report of the Surgeon General, DHEW Publication No PHS79-50066. Washington: US Department of Health, Education, and Welfare, Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health; 1979. Available from: http://profiles.nlm.nih.gov/NN/B/C/M/D/segments.html
22. US Department of Health and Human Services. The health consequences of smoking. Cancer. A report of the US Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 1982. Available from: http://profiles.nlm.nih.gov/NN/B/C/D/W/_/nnbcdw.pdf
23. Huxley R, Jamrozik K, Lam T, Barzi F, Ansary-Moghaddam A, Jiang C, et al. Impact of smoking and smoking cessation on lung cancer mortality in the Asia-Pacific region. Am J Epidemiol 2007;165:1280–6.
24. Anon. Female smokers have higher cancer risk. The Sydney Morning Herald 2007 22 March. Available from: http://www.smh.com.au/news/NATIONAL/Female-smokers-have-higher-cancer-risk/2007/03/22/1174153226747.html
25. Giles G, Thursfield V, Melbourne: Cancer Epidemiology Centre, The Cancer Council Victoria. Personal communication. Recipient, Winstanley M, 2007.
26. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000;321:323–29. Available from: http://www.bmj.com/cgi/content/abstract/321/7257/323
27. US Department of Health and Human Services. The health benefits of smoking cessation. A report of the Surgeon General. DHHS Publication No CDC 90-8416. Rockville, MD: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990. Available from: http://profiles.nlm.nih.gov/NN/B/B/C/T/_/nnbbct.pdf
28. Australian Institute of Health and Welfare. Australia's Health 2006. Canberra: AIHW; 2006. Available from: http://www.aihw.gov.au/publications/index.cfm/title/10321
29. US Department of Health and Human Services. The health consequences of smoking. Chronic obstructive lung disease: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 1984. Available from: http://profiles.nlm.nih.gov/NN/B/C/C/S/_/nnbccs.pdf
30. Rennard S, Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 2006;367:1216–19.
31. Devereux G. The ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. BMJ 2006;332:1142–4. Available from: http://www.bmj.com/cgi/reprint/332/7550/1142.pdf
32. Franklin K, G�slason T, Omenaas E, J�gi R, Jensen E, Lindberg E, et al. The influence of active and passive smoking on habitual snoring. Am J Respir Crit Care Med 2004;170:799–803.
33. Vent J, Robinson A, Gentry-Nielsen M, Conley D, Hallworth R, Leopold D, et al. Pathology of the olfactory epithelium: smoking and ethanol exposure. Laryngoscope 2004;114:1383–8.
34. Murphy C, Schubert C, Cruickshanks K, Klein B, Klein R, Nondahl D. Prevalence of olfactory impairment in older adults. JAMA 2002;288:2307–12. Available from: http://jama.ama-assn.org/cgi/reprint/288/18/2307
35. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, Volume 83. Lyon: International Agency for Research on Cancer; 2004. Available from:
http://monographs.iarc.fr/ENG/Monographs/allmonos90.php
36. Hurt R, Offord K, Croghan I, Gomez-Dahl L, Kottke T, Morse R, et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA 1996;275:1097–103.
37. English D, Giles G, Karavarsamis N, Thursfield V. Cancer survival in Victoria: Relative survival for selected cancers diagnosed from 1982 to 1997 with follow-up to 1999. Melbourne: Victorian Cancer Registry, Cancer Epidemiology Centre, The Cancer Council Victoria; 2003. Available from: http://www.cancervic.org.au/cancer1/facts/survival_monograph.htm
38. Zisman A, Nickolov A, Brand R, Gorchow A, Roy H. Associations between the age at diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for screening. Arch Intern Med 2006;166:629–34. Available from: http://archinte.ama-assn.org/cgi/reprint/166/6/629
39. Windham G, Mitchell P, Anderson M, Lasley B. Cigarette smoking and effects on hormone function in premenopausal women. Environ Health Perspect 2005;113:1285–90. Available from: http://www.ehponline.org/members/2005/7899/7899.html
40. Keeling D. Combined oral contraceptives and the risk of myocardial infarction. Ann Med 2003;35:413–18.
41. British Medical Association Board of Science, and Education & Tobacco Control Resource Centre. Smoking and reproductive life. The impact of smoking on sexual, reproductive and child health. London: British Medical Association; 2004. Available from: http://www.bma.org.uk/ap.nsf/AttachmentsByTitle/PDFsmokingreproductivelife/$FILE/smoking.pdf
42. Millett C, Wen LM, Rissel C, Smith A, Richters J, Grulich A, et al. Smoking and erectile dysfunction: findings from a representative sample of Australian men. Tob Control 2006;15:136–9. Available from: http://tc.bmjjournals.com/cgi/content/abstract/15/2/136
43. US Department of Health and Human Services. The health consequences of smoking. Nicotine addiction. A report of the Surgeon General. Rockville, MD: Center for Health Promotion and Education, Office on Smoking and Health, DHHS Publication No CDC 88–8406; 1988. Available from: http://profiles.nlm.nih.gov/NN/B/B/Z/D/segments.html
44. Laws P, Grayson N, Sullivan E. Smoking and pregnancy. AIHW Cat. No. PER 33. Sydney: AIHW National Perinatal Statistics Unit; 2006. Available from: http://www.npsu.unsw.edu.au/NPSUweb.nsf/resources/AMB_2004_2008/$file/Smoking+and+pregnancy+for+web.pdf
45. Tobacco Advisory Group of the Royal College of Physicians. Nicotine addiction in Britain. A report of the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians of London; 2000. Available from: http://www.rcplondon.ac.uk/pubs/books/nicotine/
46. Man L-X, Chang B. Maternal cigarette smoking during pregnancy increases the risk of having a child with a congenital digital anomaly. Plast Reconstr Surg 2006;117:301–8.
47. Laws P, Abeywardana S, Walker J, Sullivan E. Australia's mothers and babies 2005. Perinatal statistics series no. 20. Cat. no. PER 40. Sydney: AIHW National Perinatal Statistics Unit.; 2007. Available from: http://www.aihw.gov.au/publications/index.cfm/title/10471
48. Office of Environmental Health Hazard Assessment OEHHA, California Air Resources Board ARB, California Environmental Protection Agency Cal/EPA. Health effects of exposure to environmental tobacco smoke: Final Report, approved at the Panel's June 24, 2005 meeting. Sacramento: Office of Environmental Health Hazard Assessment; 2005. Available from: http://www.oehha.ca.gov/air/environmental_tobacco/2005etsfinal.html
49. Allen J, Hector D. Benefits of breastfeeding. NSW Public Health Bull 2005;16:42–6. Available from: http://www.health.nsw.gov.au/public-health/phb/HTML2005/marchapril05html/article3p42.htm
50. Dahlstrom A, Ebersjo C, Lundell B. Nicotine exposure in breastfed infants. Acta Paediatr 2004;93:810–16.
51. Noakes P, Hale J, Thomas R, Lane C, Devadason S, Prescott S. Maternal smoking is associated with impaired neonatal toll-like receptor TLR mediated immune responses. European Respiratory Journal 2006;28:721–9.
52. US Department of Health and Human Services. The health consequences of involuntary exposure to tobacco smoke: A report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2006. Available from: http://www.cdc.gov/tobacco/sgr/sgr_2006/index.htm
53. DiFranza J, Aligne A, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004;113:1007–15. Available from: http://pediatrics.aappublications.org/cgi/reprint/113/4/S1/1007
54. Wakschlag L, Leventhal B, Pine D, Pickett K, Carter A. Elucidating early mechanisms of developmental psychopathology: the case of prenatal smoking and disruptive behaviour. Child Development 2006;77:893–906.
55. Al Mamun A, Lawlor D, Alati R, O'Callaghan M, Williams G, Najman J. Does maternal smoking during pregnancy have a direct effect on future offspring obesity? Evidence from a prospective birth cohort study. Am J Epidemiol 2006;164:317–25. Available from: http://aje.oxfordjournals.org/cgi/reprint/164/4/317
56. Buka SL, Shenassa ED, Niaura R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: A 30-year prospective study. Am J Psychiatry 2003;160:1978–84. Available from: http://ajp.psychiatryonline.org/cgi/content/full/160/11/1978
57. Al Mamun A, O'Callaghan FV, Alati R, O'Callaghan M, Najman JM, Williams GM, et al. Does maternal smoking during pregnancy predict the smoking patterns of young adult offspring? A birth cohort study. Tob Control 2006;15:452–7. Available from: http://tobaccocontrol.bmj.com/cgi/reprint/15/6/452
58. Cornelius M, Leech S, Goldschmidt L, Day N. Is prenatal tobacco exposure a risk factor for early adolescent smoking? A follow-up study. Neurotoxicol Teratol 2005;27:667–76.
59. Arcavi L, Benowitz N. Cigarette smoking and infection. Arch Intern Med 2004;16:2206–16. Available from: http://archinte.ama-assn.org/cgi/content/full/164/20/2206
60. D'Souza G, Kreimer A, Viscidi R, Pawlita M, Fakhry C, Koch W, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944–56.
61. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst 2003;95:1772–83. Available from: http://jnci.oxfordjournals.org/cgi/content/abstract/jnci;95/23/1772
62. Furber AS, Maheswaran R, Carroll CJ, Newell JN. Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? Sex Transm Infect 2006;83:41–6.
63. Gajalakshmi V, Peto R, Kanaka T, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43,000 adult male deaths and 35,000 controls. Lancet 2003;362:507–15.
64. Thornton J, Edwards R, Mitchell P, Harrison R, Buchan I, Kelly S. Smoking and age-related macular degeneration: a review of association. Eye 2005;19:935–44.
65. Khan J, Thurlby D, Shahid H, Clayton D, Yates J, Bradley M, et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 2006;90:75–80. Available from: http://bjo.bmj.com/cgi/content/full/90/1/75
66. Birrenbach T, Bocker U. Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology and therapeutic implications. Inflamm Bowel Dis 2004;10:848–59.
67. Wong P, Christie J, Wark J. The effects of smoking on bone health. Clin Sci 2007;113:233–41. Available from: http://www.clinsci.org/cs/113/0233/1130233.pdf
68. Nelson HD, Nevitt MC, Scott JC, Stone KL, Cummings SR. Smoking, alcohol, and neuromuscular and physical function of older women. Study of Osteoporotic Fractures Research Group. JAMA 1994;272:1825–31.
69. Model D. Smoker's face: an underrated clinical sign? Br Med J 1985;291:1760–2. Available from: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1419177&blobtype=pdf
70. Ernster V, Grady D, Miike R, Black D, Selby J, Kerlikowske K. Facial wrinkling in men and women, by smoking status. Am J Public Health 1995;85:78–82. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=7832266
71. Yin L, Morita A, Tsuji T. Skin ageing induced by ultraviolet exposure and tobacco smoking: evidence from epidemiological and molecular studies. Photodermatol Photoimmunol Photomed 2001;17:178–83.
72. Koh J, Kang H, Choi S, Kim H. Cigarette smoking associated with premature facial wrinkling: image analysis of facial skin replicas. Int J Dermatol 2002;41:21–7.
73. Leung W, Harvey I. Is skin ageing in the elderly caused by sun exposure or smoking? Br J Dermatol 2002;147:1187–91.
74. Kennedy C, Bastiaens M, Bajdik C, Willemze R, Westerndorp R, Bouwes Bavinck J, et al. Effect of smoking and sun on the aging skin. J Invest Dermatol 2003;120:548–54.
75. Raitio A, Kontinen J, Rasi M, Bloigu R, R�ning J, Oikarinen A. Comparison of clinical and computerised image analyses in the assessment of skin ageing in smokers and non-smokers. Acta Derm Venereol 2004;84:422–7.
76. Kadunce D, Burr R, Gress R, Kanner R, Lyon J, Zone J. Cigarette smoking: risk factor for premature facial wrinkling. Ann Intern Med 1991;114:840–4.
77. Placzek M, Kerkmann U, Bell S, Koepke P, Przybilla B. Tobacco smoke is phototoxic. Br J Dermatol 2004;150:991–3.
78. Helfrich Y, Yu L, Ofori A, Hamilton T, Lambert J, King A, et al. Effect of smoking on ageing of photoprotected skin. Arch Dermatol 2007;143:397–402.
79. Patel B, Loo W, Tasker A, Screaton N, Burrows N, Silverman E, et al. Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax 2006;61:568–71. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=7832266
80. Frieman A, Bird G, Metelitsa A, Barankin B, Lauzon G. Cutaneous effects of smoking. J Cutan Med Surg 2004;8:415–23.
81. Behnam S, Behnam S, Koo J. Smoking and psoriasis. Skinmed 2005;4:174–6.
82. Australian and New Zealand College of Anaesthetists. Statement on smoking as related to the perioperative period. Melbourne: Australian and New Zealand College of Anaesthetists; 2001. Available from: http://www.anzca.edu.au/publications/profdocs/profstandards/ps12_2001.htm
83. Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob Control 2006;15:352–8. Available from: http://tc.bmj.com/cgi/content/abstract/15/5/352
84. Zevin S, Benowitz N. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999;36:425–38.
85. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev 2005;14:2287–93. Available from: http://cebp.aacrjournals.org/cgi/reprint/14/10/2287
86. Sanderson Cox L, Africano N, Tercyak K, Taylor K. Nicotine dependence treatment for patients with cancer. Review and recommendations. Cancer 2003;98:632–44. Available from: http://www3.interscience.wiley.com/cgi-bin/fulltext/104540005/PDFSTART
87. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993;328:159–63.
88. Diabetes Australia. What is diabetes? Canberra: Diabetes Australia, Updated November 2005 [viewed 10 July 2007]. Available from:
http://www.diabetesaustralia.com.au/_lib/doc_pdf/resources/factsheets/WHAT_IS_DIABETES.pdf
89. Diabetes Australia. Staying well with diabetes by preventing complications. Canberra: Diabetes Australia, Updated November 2005 [viewed 10 July 2007]. Available from: http://www.diabetesaustralia.com.au/_lib/doc_pdf/resources/factsheets/STAYING_WELL.pdf
90. Taylor R, Davison JM. Type 1 diabetes and pregnancy. BMJ 2007;334:742–5.
91. Sherman JJ. The impact of smoking and quitting smoking on patients with diabetes. Diabetes Spectr 2005;184:202–8. Available from: http://spectrum.diabetesjournals.org/cgi/reprint/18/4/202
92. Haire-Joshu D, Glasgow R, Tibbs T. Smoking and diabetes. Diabetes Care 1999;22:1887–98. Available from: http://care.diabetesjournals.org/cgi/reprint/22/11/1887
93. Eliasson B. Cigarette smoking and diabetes. Prog Cardiovasc Dis 2003;45:405–13.
94. Schulze M, Hu F. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 2005;26:445–67.
95. Patja K, Jousilahti P, Hu G, Valle T, Qiao Q, Tuomilehto J. Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-aged Finnish men and women. J Internal Medicine 2005;258:356–62.
96. Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, Kiefe CI. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ 2006;332:1064–9. Available from: http://www.bmj.com/cgi/content/full/332/7549/1064
97. Manson J, Ajani U, Liu S, Nathan D, Hennekens C. A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med 2000;109:538–42.
98. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int. J. Epidemiol. 2001;30:540–6. Available from: http://ije.oxfordjournals.org/cegi/reprint/30/3/540
99. Eliasson M, Asplund K, Nasic S, Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. Journal of Internal Medicine 2004;256:101–10. Available from: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365–2796.2004.01344.x
100. Willi C, Bodenmann P, Ghali W, Faris P, Cornuz J. Active smoking and the risk of Type 2 diabetes. A systematic review and meta-analysis. JAMA 2007;298:2654–64.
101. John U, Hanke M, Meyer C, Volzke H, Baumeister S, Alte D. Tobacco smoking in relation to pain in a national general population survey. Prev Med 2006;43:477–81.
102. Phillips B, Danner F. Cigarette smoking and sleep disturbance. Arch Intern Med 1995;155:734–7.
103. Zhang L, Samet J, Caffo B, Punjabi N. Cigarette smoking and nocturnal sleep architecture. Am J Epidemiol 2006;164:529–37. Available from: http://www.anzca.edu.au/publications/profdocs/profstandards/ps12_2001.htm
104. Bush R, Wooden M. Smoking and absence from work: Australian evidence. Soc Sci Med 1995;41:437–46.
105. Young K, Regan M, Hammer M. Driver distraction: a review of the literature. Report 206. Clayton: Monash University Accident Research Centre; 2003. Available from: http://www.monash.edu.au/muarc/reports/muarc206.pdf
106. McEvoy S, Stevenson M, Woodward M. The impact of driver distraction on road safety: results from a representative survey in two Australian states. Injury Prevention 2006;12:242–7.
107. Stutts J, Reinfurt D, Rodgman E. The role of driver distraction in crashes: an analysis of 1995–1999 Crashworthiness Data System Data. Annu Proc Assoc Adv Automot Med 2001;45:287–301.
108. Brison R. Risk of automobile accidents in cigarette smokers. Can J Public Health 1990;81:102–6.
109. Collins D, Lapsley H. Economic aspects of drug taking and road safety. In: Enquiry into the effects of drugs other than alcohol on road safety in Victoria. First report incorporating collected papers. Melbourne: Road Safety Committee, Parliament of Victoria; 1995. Available from:
http://www.parliament.vic.gov.au/rsc/drugs/drugcola.htm
110. Leistikow BN, Martin DC, Samuels SJ. Injury death excesses in smokers: a 1990–95 United States national cohort study. Inj Prev 2000;6:277–80. Available from: http://injuryprevention.bmj.com/cgi/reprint/6/4/277
111. Wen CP, Tsai SP, Cheng TY, Chan HT, Chung WSI, Chen CJ. Excess injury mortality among smokers: a neglected tobacco hazard. Tob Control 2005;14suppl_1:i28–32. Available from: http://tobaccocontrol.bmj.com/cgi/content/abstract/14/suppl_1/i28
112. Leistikow BN, Martin D, Jacobs J, Rocke D. Smoking as a risk factor for injury death: a meta-analysis of cohort studies. Prev Med 1998;27:871–8.
113. Chapman S, Balmain A. Time to legislate for fire-safe cigarettes in Australia [Editorial]. Med J Aust 2004;181:292–3. Available from:
http://www.mja.com.au/public/issues/181_06_200904/cha10373_fm.html
114. Hoy M, Morton S. NCIS Database Search. Deaths associated with fires caused by cigarettes between 1 June 2000–30 June 2006. Report produced for NSW Fire Brigades. Southbank, Melbourne: National Coroners Information System, Victorian Institute of Forensic Medicine; 2006. Available from: http://tobacco.health.usyd.edu.au/site/supersite/resources/pdfs/CigDeathsReport%20NCIS%203Oct_2006%20V1.pdf
115. McGee D, Brabson T, McCarthy J, Picciotti M. Four-year review of cigarette ingestions in children. Pediatr Emerg Care 1995;11:13–16.
116. Woolf A, Burkhart K, Caraccio T, Litovitz T. Childhood poisoning involving transdermal nicotine patches. Pediatrics 1997;99:e4. Available from: http://pediatrics.aappublications.org/cgi/content/abstract/99/5/e4
117. Therapeutic Goods Administration. Standard for the uniform scheduling of drugs and poisons SUSDP. Canberra: Department of Health and Ageing; 2007. Available from: http://www.tga.gov.au/ndpsc/susdp.htm
118. McBride JS, Altman DG, Klein M, White W. Green tobacco sickness. Tob Control 1998;7:294–8. Available from: http://tobaccocontrol.bmj.com/cgi/reprint/7/3/294
119. Schmitt N, Schmitt J, Kouimintzis D, Kirch W. Health risks in tobacco farm workers – a review of the literature. J Public Health 2007;15:255–64.
120. Arcury TA, Quandt SA, Preisser JS. Predictors of incidence and prevalence of green tobacco sickness among Latino farmworkers in North Carolina, USA. J Epidemiol Community Health 2001;55:818–24. Available from: http://jech.bmj.com/cgi/reprint/55/11/818
121. US Department of Health and Human Services. Preventing tobacco use among young people. A report of the Surgeon General, 1994. Atlanta, Georgia: Public Health Service, Centers for Disease Control and Prevention, Office on Smoking and Health; 1994. Available from: http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_1994/index.htm
122. Patton G, Coffey C, Carlin J, Sawyer S, Wakefield M. Teen smokers reach their mid twenties. J Adolesc Health 2006;39:214–20.
123. Talmud P, Stephens J, Hawe E, Demissie S, Cupples L, Hurel S, et al. The significant increase in cardiovascular disease risk in APOE e4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 2005;69:613–22.
124. Amos C, Xu W, Spitz M. Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res 1999;151:3–12.
125. Devereux TR, Taylor JA, Barrett JC. Molecular mechanisms of lung cancer. Interaction of environmental and genetic factors. Giles F. Filley Lecture. Chest 1996;1093:14S–19. Available from: http://www.chestjournal.org/cgi/reprint/109/3/14S
126. Hall W, Madden P, Lynskey M. The genetics of tobacco use: methods, findings and policy implications. Tob Control 2002;11:119–24. Available from: http://tobaccocontrol.bmj.com/cgi/reprint/11/2/119.pdf
127. Hall W. A research agenda for assessing the potential contribution of genomic medicine to tobacco control. Tob Control 2007;16:53–8. Available from: http://tobaccocontrol.bmj.com/cgi/reprint/16/1/53.pdf
128. Wang X, Mahaney M. Genotype-specific effects of smoking on risk of CHD [Editorial]. Lancet 2001;358:87–8.
129. Anstey K, von Sanden C, Salim A, O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007;166:367–78.
130. Driscoll T, Steenland K, Imel Nelson D, Leigh J. Occupational airborne particulates. Assessing the environmental burden of disease at national and local levels. Environmental Burden of Disease Series, No 7. Geneva: World Health Organization; 2004. Available from: http://www.who.int/quantifying_ehimpacts/publications/en/ebd7.pdf
131. US Department of Health and Human Services. The health consequences of smoking: cancer and chronic lung disease in the workplace. A report of the Surgeon General. DHHS Publication No PHS 85–50207. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 1985. Available from: http://profiles.nlm.nih.gov/NN/B/C/B/N/segments.html
132. Stewart B, Kleihues P, Editors. IARC World Cancer Report. Lyon: IARCPress; 2003.
133. Department of the Environment and Heritage. National standards for criteria air pollutants in Australia. Air quality fact sheet. Canberra: Department of the Environment and Heritage; 2005. Available from: http://www.environment.gov.au/atmosphere/airquality/publications/standards.html
134. Department of the Environment and Heritage. Particles. Air quality fact sheet. Canberra: Department of the Environment and Heritage; 2005. Available from: http://www.environment.gov.au/atmosphere/airquality/publications/particles.html
135. Department of the Environment and Heritage. Nitrogen dioxide. Air quality fact sheet. Canberra: Department of the Environment and Heritage; 2005. Available from: http://www.environment.gov.au/atmosphere/airquality/publications/nitrogendioxide.html
136. Department of the Environment and Heritage. Sulphur dioxide. Air quality fact sheet. Canberra: Department of the Environment and Heritage; 2005. Available from: http://www.environment.gov.au/atmosphere/airquality/publications/sulfurdioxide.html
137. Department of the Environment and Heritage. Carbon monoxide. Air quality fact sheet. Canberra: Department of the Environment and Heritage; 2005. Available from: http://www.environment.gov.au/atmosphere/airquality/publications/carbonmonoxide.html
138. Department of the Environment and Heritage. Lead. Air quality fact sheet. Canberra: Department of the Environment and Heritage; 2005. Available from: http://www.environment.gov.au/atmosphere/airquality/publications/leadfs.html
139. Australian Bureau of Statistics. Measures of Australia's progress. Cat. No. 1370.0 The air and atmosphere. Canberra: Australian Bureau of Statistics; 2006. Available from: http://www.ausstats.abs.gov.au/ausstats/subscriber.nsf/0/47132EE72AC3581DCA25717F0004ACE8/$File/13700_2006.pdf
140. Invernizzi G, Ruprecht A, Mazza R, Rossetti E, Sasco A, Nardini S, et al. Particulate matter from tobacco versus diesel car exhaust: an educational perspective. Tob Control 2004;13:219–21. Available from: http://tc.bmjjournals.com/cgi/content/abstract/13/3/219
141. Australian Bureau of Statistics. Australia Now. Environment. Air Pollution. Cat. No. 1301.0. Canberra: Australian Bureau of Statistics; 2004. Available from: http://www.abs.gov.au/ausstats/abs@.nsf/0/8f1a0bea81c1d6eeca256dea00053a5e?OpenDocument
142. Brown S. Indoor air quality, Australia: State of the Environment Technical Paper Series Atmosphere. Canberra: Department of the Environment, Sport and Territories; 1997. Available from: http://www.deh.gov.au/soe/techpapers/series1/pubs/12indora.pdf
143. Drope J, Bialous SA, Glantz SA. Tobacco industry efforts to present ventilation as an alternative to smoke-free environments in North America. Tob Control 2004;1390001:41i–47. Available from: http://tc.bmjjournals.com/cgi/content/abstract/13/suppl_1/i41
144. Burns D, Benowitz NL. Public health implications of changes in cigarette design and marketing. In: Tobacco Control Research. Smoking and Tobacco Control Monographs. Monograph 13: Risks associated with smoking cigarettes with low tar machine-measured yields of tar and nicotine. Bethesda, MD: National Cancer Institute, US National Institutes of Health; 2001. Available from: http://www.cancercontrol.cancer.gov/tcrb/monographs/13/m13_1.pdf
145. King W, Carter SM, Borland R, Chapman S, Gray N. The Australian tar derby: the origins and fate of a low tar harm reduction programme. Tob Control 2003;12:61iii–70. Available from: http://tobaccocontrol.bmj.com/cgi/content/full/12/suppl_3/iii61
146. US Department of Health and Human Services. The health consequences of smoking. The changing cigarette. A report of the Surgeon General. Washington DC: US Department of Health and Human Services, Public Health Service, Office of Smoking and Health; 1981. Available from: http://profiles.nlm.nih.gov/NN/B/B/S/N/segments.html
147. McNeill A. Harm reduction. BMJ 2004;328:885–7. Available from: http://www.bmj.com/cgi/reprint/328/7444/885
148. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: Detailed Findings. Drug Statistics Series No. 16, AIHW Cat. No. PHE 66. Canberra: AIHW; 2005. Available from: http://www.aihw.gov.au/publications/index.cfm/title/10190
149. Maziak W, Ward KD, Afifi Soweid RA, Eissenberg T. Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tob Control 2004;13:327–33. Available from: http://tobaccocontrol.bmj.com/cgi/content/abstract/13/4/327
150. Auditor-General. Administration of tobacco excise. Audit report No. 55, 2001–02 Performance Audit. Canberra: Australian National Audit Office, Commonwealth of Australia; 2002. Available from: http://www.anao.gov.au/uploads/documents/2001–02_Audit_Report_55.pdf
151. Bittoun R. 'Chop chop' tobacco smoking [Letter]. Med J Aust 2002;177:686–7. Available from: http://www.mja.com.au/public/issues/177_11_021202/bittoun_021202.pdf
152. Lindorff K. Tobacco — time for action. National Aboriginal and Torres Strait Islander Tobacco Control Project. Final Report. Canberra: National Aboriginal Community Controlled Health Organisation NACCHO; 2002. Available from: http://www.weftweb.net/naccho/Files/NACCHO_Tobacco_report.pdf
153. Bittoun R. The medical consequences of smoking 'chop chop' tobacco. Report prepared for the Commonwealth Department of Health and Ageing. Canberra: Department of Health and Ageing; 2004. Available from: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/phd-pub-tobacco-chopchop-cnt.htm/$FILE/chopchop.pdf
154. National Cancer Institute. Cigars: health effects and trends. Smoking and Tobacco Control Monographs, Monograph 9. Rockville, MD: National Cancer Institute, US National Institutes of Health; 1998. Available from: http://cancercontrol.cancer.gov/tcrb/monographs/9/index.html
155. Henley S, Thun M, Chao A, Calle E. Association between exclusive pipe smoking and mortality from cancer and other diseases. J Natl Cancer Inst 2004;96:853–61. Available from: http://jnci.oxfordjournals.org/cgi/reprint/96/11/853
156. Wald N, Watt H. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. BMJ 1997;314:1860–3. Available from: http://www.bmj.com/cgi/content/full/314/7098/1860
157. Knishkowy B, Amitai Y. Water-pipe narghile smoking: an emerging health risk behaviour. Pediatrics 2005;116:113–19. Available from: http://pediatrics.aappublications.org/cgi/reprint/116/1/e113.pdf
158. Wolfram R, Chehne F, Oguogho A, Sinzinger H. Narghile water pipe smoking influences platelet function and iso-eicosanoids. Life Sci 2003;74:47–53.
159. Maziak W WK, Eissenberg T. Interventions for waterpipe smoking cessation. Cochrane Database Syst Rev 2007:Art. No.: CD005549. DOI: 10.1002/14651858.CD005549.pub2. Available from: http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005549/pdf_fs.html
160. World Health Organization Regional Office for the Eastern Mediterranean. Tobacco use in shisha: studies on waterpipe smoking in Egypt. Cairo: WHO Regional Office for the Eastern Mediterranean, Egyptian Smoking Prevention Research Institute; 2006. Available from:
http://www.emro.who.int/TFI/PDF/shisha.pdf
161. Rastam S, Ward K, Eissenberg T, Maziak W. Estimating the beginning of the waterpipe epidemic in Syria. BMC Public Health 2004;432:doi:10.1186/1471–2458–4–32. Available from: http://www.biomedcentral.com/content/pdf/1471–2458–4–32.pdf
162. Asfar T, Ward K, Eissenberg T, Maziak W. Comparison of patterns of use, beliefs, and attitudes related to waterpipe between beginning and established smokers. BMC Public Health 2005;519:doi:10.1186/1471–2458–5–19. Available from: http://www.biomedcentral.com/1471-2458/5/19
163. American Lung Association. Tobacco Policy Trend Alert. An emerging deadly trend: waterpipe tobacco use. Washington DC: American Lung Association; 2007. Available from: http://www.lungusa2.org/embargo/slati/Trendalert_Waterpipes.pdf
164. Maziak W, Ward K, Eissenberg T. Factors related to frequency of narghile waterpipe use: the first insights on tobacco dependence in narghile users. Drug Alcohol Dependence 2004;76:101–6.
165. Munckhof W, Konstantinos A, Wamsley M, Mortlock M, Gilpin C. A cluster of tuberculosis associated with use of a marijuana water pipe. Int J Tuberc Lung Dis 2003;7:860–5.
166. Baron J. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull 1996;52:58–73. Available from: http://bmb.oxfordjournals.org/cgi/reprint/52/1/58
167. Allam M, Campbell M, Hofman A, Del Castillo A, Navajas R-C. Smoking and Parkinson's disease: systematic review of prospective studies. Movement Disorders 2004;19:614–21.
168. Quik M. Smoking, nicotine and Parkinson's disease. Trends in Neurosciences 2004;27:561–8.
169. The Diverse Populations Collaboration. Smoking, body weight, and CHD mortality in diverse populations. Preventive Medicine 2004;38:834–40.
170. Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N, et al. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obesity Res 2005;13:1466–75. Available from: http://www.obesityresearch.org/cgi/reprint/13/8/1466
171. Filozof C, Fern�ndez Pinilla M, Fern�ndez-Cruz A. Smoking cessation and weight gain. Obes Rev 2004;5:95–103.
172. Froom P, Melamed S, Benbassat J. Smoking cessation and weight gain. J Fam Pract 1998;46:460–4.
173. Lasser K, Boyd J, Woolhandler S, Himmelstein D, McCormick D, Bor D. Smoking and mental illness. A population-based prevalence study. JAMA 2000;284:2606–10. Available from: http://jama.ama-assn.org/cgi/content/full/284/20/2606
174. McNeill A. Smoking and mental health – a review of the literature. London: Smokefree London Programme; 2001. Available from:
http://www.ash.org.uk/html/policy/menlitrev.pdf
175. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Morgan V, et al. People living with psychotic Illness: an Australian study 1997–98. Canberra: Mental Health Branch, Commonwealth Department of Health and Aged Care; 1999.
176. Lawrence D, Holman C, Jablensky A. Duty to Care. Preventable physical illness in people with mental illness. Perth: The University of Western Australia; 2001.
177. Ministerial Council on Drug Strategy and Department of Health and Ageing. National Tobacco Strategy 2004–2009. Canberra: Commonwealth of Australia; 2005. Available from: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/phd-pub-tobacco-tobccstrat2-cnt.htm
178. Rivera-Hidalgo F, Shulman J, Beach M. The association of tobacco and other factors with recurrent aphthous stomatitis in a US adult population. Oral Dis 2004;10:335–45.
179. Grady D, Ernster V, Stillman L, Greenspan J. Smokeless tobacco use prevents aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1992;74:463–5.
180. Ussher M, West R, Steptoe A, McEwen A. Increase in common cold symptoms and mouth ulcers following smoking cessation. Tob Control 2003;12:86–8. Available from: http://tc.bmjjournals.com/cgi/content/abstract/12/1/86
181. English D, Holman C, Milne E, Winter M, Hulse G, Codde J, et al. The quantification of drug-caused morbidity and mortality in Australia, 1992. Canberra: Commonwealth Department of Human Services and Health; 1995.
182. Ridolfo B, Stevenson C. The quantification of drug-caused mortality and morbidity in Australia, 1998. Canberra: Australian Institute of Health and Welfare; 2001. Available from: http://www.aihw.gov.au/publications/index.cfm/title/6461
183. Holman C, Armstrong B, Arias L, Martin CA, Hatton WM, Hayward LD, et al. The quantification of drug caused morbidity and mortality in Australia 1988, Parts 1 and 2. Canberra: Commonwealth Department of Health, Housing, Local Government and Community Services; 1990.
184. Peto R, Lopez AD, Boreham J, Thun M, Heath Jr C. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992;339:1268–78.
185. Peto R, Watt J, Boreham J. Deaths from smoking: an electronic resource. Deaths from smoking in Australia. Geneva: International Union Against Cancer UICC, 2006, [viewed 18 June 2007]. Available from: http://www.deathsfromsmoking.net/download%20files/Country%20presentations/Australia/Australia%20data.pdf
186. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control 2004;13:388–95. Available from: http://tc.bmjjournals.com/cgi/content/abstract/13/4/388
187. Turrell G, Mathers C. Socioeconomic status and health in Australia. Med J Aust 2000;172:434–8.
188. Draper G, Turrell G, Oldenburg B. Health inequalities in Australia, mortality. Health inequalities monitoring series No 1 AIHW Cat. No. PHE 55. Canberra: Queensland University of Technology and the Australian Institute of Health and Welfare; 2005. Available from: http://www.aihw.gov.au/publications/index.cfm/title/10041
189. Siahpush M, English D, Powles J. The contribution of smoking to socioeconomic differentials in mortality: results from the Melbourne Collaborative Cohort Study, Australia. J Epidemiol Community Health 2006;60:1077–9.
190. Jha P, Peto R, Zatonski W, Boreham J, Jarvis MJ, Lopez AD. Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet 2006;368:367–70.
191. Honeyrose Products Ltd. Company website. Ipswich UK: Honeyrose Products Ltd, 2007, [viewed 20 June 2007]. Available from: http://www.honeyrose.co.uk/index.html
192. Groman E, Bernhard G, Blauensteiner D, Kunze U. A harmful aid to stopping smoking [Letter]. Lancet 1999;353:466–7.
193. Calafat AM, Polzin GM, Saylor J, Richter P, Ashley DL, Watson CH. Determination of tar, nicotine, and carbon monoxide yields in the mainstream smoke of selected international cigarettes. Tob Control 2004;13:45–51. Available from: http://tc.bmj.com/cgi/content/abstract/13/1/45
194. Chen A, Glantz SA, Tong E. Asian herbal-tobacco cigarettes: 'not medicine but less harmful'? Tob Control 2007;16:e3. Available from:
http://tobaccocontrol.bmj.com/cgi/reprint/16/2/e3.pdf
195. Zimmerman C. Herbal cigarettes: blending ancient Chinese medicine. Tobacco Reporter 1991;March:29.
196. National Institute on Drug Abuse. NIDA Infofacts. Marijuana. Rockville, MD: US Department of Health and Human Services; 2006. Available from: http://www.drugabuse.gov/infofacts/marijuana.html
197. Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey: first results. Drug Statistics Series No. 20, AIHW Cat. No. PHE 58. Canberra: AIHW; 2008. Available from: http://www.aihw.gov.au/publications/index.cfm/title/10579
198. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004;28:849–63.
199. Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, et al. The effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007;62:1058–63.
200. Taylor D, Hall W. Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand. Int Med J 2003;33:310–13. Available from: http://www.thoracic.org.au/cannabispositionpaper.pdf
201. Fergusson DM, Poulton R, Smith PF, Boden JM. Cannabis and psychosis. BMJ 2006;332:172–5. Available from: http://www.bmj.com/cgi/reprint/332/7534/172?ijkey=c46fbb1186b5ae45363e1e165d5f28937d3686b9
202. Moore T, Zammit S, Lingford-Hughes A, Barnes T, Jones P, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007;370:319–27.
203. Hall W. Cannabis use and the mental health of young people. Aust NZ J Psych 2006;40:105–13.
204. Lawrence S, Collin J. Competing with kreteks: transnational tobacco companies, globalisation, and Indonesia. Tob Control 2004;13Suppl II:ii96–103. Available from: http://tobaccocontrol.bmj.com/cgi/reprint/13/suppl_2/ii96
205. Malson J, Lee E, Murty R, Moolchan E, Pickworth W. Clove cigarette smoking: biochemical, physiological, and subjective effects. Pharmacol Biochem Behav 2003;74:739–45.
206. Mangunnegoro H, Sutoyo D. Environmental and occupational lung diseases in Indonesia. Respirology 1996;1:85–93.
207. American Medical Association Council on Scientific Affairs. Council Report: evaluation of the health hazard of clove cigarettes. JAMA 1988;260:3641–4.
208. Centers for Disease Control and Prevention. Tobacco use, access and exposure to tobacco media among middle and high school students-United States, 2004. Morb Mortal Weekly Rep 2005;54:297–301. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5412a1.htm
209. Centers for Disease Control and Prevention. Bidi use among urban youth-Massachusetts, March-April 1999. Morb Mortal Weekly Rep 1999;48:796–9. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4836a2.htm
210. Shafey O, Dolwick S, Guindon G, editors. Tobacco control country profiles. Atlanta, GA: American Cancer Society, World Health Organisation, International Union Against Cancer; 2003. Available from: http://www.cancer.org/docroot/PRO/content/PRO_1_1_Tobacco_Control_Country_Profiles.asp
211. Rahman M, Fukui T. Bidi smoking and health. Public Health 2000;114:123–7.
212. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. 'Overall, illicit drug use by American teens continues gradual decline in 2007.' [Press Release, 11 December 2007]. Ann Arbor, MI: University of Michigan News Service, 2007, [viewed 13 December 2007]. Available from: http://www.monitoringthefuture.org/data/07data.html#2007data-drugs
213. Watson C, Polzin G, Calafat A, Ashley D. Determination of tar, nicotine, and carbon monoxide yields in the smoke of bidi cigarettes. Nicotine Tob Res 2003;5:747–53.
214. Stanfill S, Calafat A, Brown C, Polzin G, Chiang J, Watson C, et al. Concentrations of nine alkenylbenzenes, coumarin, piperonal and pulegone in Indian bidi cigarette tobacco. Food and Chemical Toxicology 2003;41:303–317.
215. Gupta P, Mehta H. Cohort study of all-cause mortality among tobacco users in Mumbai, India. Bulletin of the World Health Organization 2000;78:887–83.
216. World Health Organization, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 85: Betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. Summary of data reported and evaluation. Lyon: IARC; 2004. Available from: http://monographs.iarc.fr/ENG/Monographs/vol85/volume85.pdf
217. National Cancer Institute, Centers for Disease Control, Stockholm Centre of Public Health. Smokeless Tobacco Factsheets. Prepared for the 3rd International Conference on Smokeless Tobacco, September 22–25, 2002. Atlanta: Centers for Disease Control and Prevention; 2002. Available from: http://cancercontrol.cancer.gov/tcrb/stfact_sheet_combined10–23–02.pdf
218. World Health Organization. Regulation urgently needed to control growing list of deadly tobacco products [Media Release, 30 May 2006]. Geneva: World Health Organization, 2007, [viewed 20 June 2007]. Available from: http://www.who.int/mediacentre/news/releases/2006/pr28/en/
219. Watson C, Fleming J, Alexander K. A survey of drug use patterns in Northern Territory Aboriginal Communities: 1986–1987. Darwin: Northern Territory Department of Health and Community Services; 1988.
220. Gilchrist D. Smoking prevalence among Aboriginal women. Aboriginal and Islander Health Worker Journal 1998;22:4–6.
221. Sachdev P, Chapman S. Availability of smokeless tobacco products in south Asian grocery shops in Sydney, 2004 [Letter]. Med J Aust 2005;183:334. Available from: http://www.mja.com.au/public/issues/183_06_190905/letters_190905_fm-1.html
222. World Health Organization Scientific Advisory Committee on Tobacco Products Regulation. Recommendation on smokeless tobacco products. Geneva: WHO; 2002. Available from: http://www.who.int/tobacco/global_interaction/tobreg/brisbane_2002_smokeless/en/
223. Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effect of smokeless tobacco snus on smoking and public health in Sweden. Tob Control 2003;12:349–59. Available from: http://tc.bmjjournals.com/cgi/content/abstract/12/4/349
224. World Health Organisation. Smokeless tobacco control. Technical report series no 773. Geneva: WHO; 1988.
225. Teo K, Ounpuu S, Hawken S, Pandey M, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006;368:647–58.
226. Luo J, Weimin Y, Zendehdel K, Adami J, Adami H-O, Boffetta P, et al. Oral use of Swedish moist snuff snus and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007;369:2015–20.
227. Broadstock M. Systematic review of the health effects of modified smokeless tobacco products. New Zealand Health Technology Assessment NZHTA Report. Christchurch: Department of Public Health and General Practice, Christchurch School of Medicine and Health Sciences; 2007. Available from: http://nzhta.chmeds.ac.nz/publications/smokeless_tobacco.pdf
228. Ramstrom LM, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 2006;15:210–14. Available from: http://tobaccocontrol.bmj.com/cgi/reprint/15/3/210.pdf
229. Gartner C, Hall W, Vos T, Bertram M, Wallace A, Lim S. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 2007;369:2010–14.
230. Bates C, Fagerstrom K, Jarvis MJ, Kunze M, McNeill A, Ramstrom L. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health. Tob Control 2003;12:360–7. Available from: http://tc.bmjjournals.com/cgi/content/abstract/12/4/360
231. Gray N. Mixed feelings on snus. Lancet 2005;366:966–7.
232. Foulds J, Kozlowski L. Snus—what should the public health response be? Lancet 2007;369:1976–8.
233. Dick A. Smokeless tobacco in Australia. In: Aoki M, Hisamichi S, Tominaga S, editors. Sixth World Conference on Smoking and Health; 1987; Tokyo: Excerpta Medica International Congress Series No 780. Elsevier Science Publisers BV Biomedical Division; 1987.
234. Attorney-General's Department, Commonwealth of Australia. Trade Practices Act 1974 and Amendments. ComLaw Commonwealth of Australia Law. Incorporating the Federal Register of Legislative Instruments. Canberra: Commonwealth of Australia, 2007, [viewed 18 June 2007]. Available from: http://www.comlaw.gov.au/comlaw/management.nsf/lookupindexpagesbyid/IP200401339?OpenDocument
235. Siahpush M, McNeill A, Hammond D, Fong GT. Socioeconomic and country variations in knowledge of health risks of tobacco smoking and toxic constituents of smoke: results from the 2002 International Tobacco Control ITC Four Country Survey. Tob Control 2006;15suppl 3:iii65–70. Available from: http://tobaccocontrol.bmj.com/cgi/reprint/15/suppl_3/iii65
236. Wakefield M, Freeman J, Inglis G. Changes associated with the National Tobacco Campaign: results of the third and fourth follow-up surveys, 1997–2000. In: Hassard K, editor. Australia's National Tobacco Campaign. Evaluation Report Volume 3. Canberra: Australian Government Department of Health and Ageing; 2004. Available from: http://www.quitnow.info.au/internet/quitnow/publishing.nsf/Content/E52EA9EEDA41F927CA2571680081F298/$File/tobccamp3.pdf
237. White V, Tan N, Wakefield M, Hill D. Do adult focused anti-smoking campaigns have an impact on adolescents? The case of the Australian National Tobacco Campaign. Tob Control 2003;1290002:23ii–29. Available from: http://tc.bmjjournals.com/cgi/content/abstract/12/suppl_2/ii23
238. Dillard A, McCaul K, Klein W. Unrealistic optimism in smokers: implications for smoking myth endorsement and self-protective motivation. J Health Communication 2006;11:93–102.
239. Tverdal A, Bjartveit K. Health consequences of reduced daily cigarette consumption. Tob Control 2006;15:472–80. Available from:
http://tobaccocontrol.bmj.com/cgi/reprint/15/6/472
240. Danaei G, Vander Hoorn S, Lopez AD, Murray C, Ezzati M, and the Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784–93.
241. Guindon G, Boisclair D. Past, current and future trends in tobacco use. Health, Nutrition and Population HNP Discussion Paper. Economics of Tobacco Control Paper No 6. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2003. Available from: http://www1.worldbank.org/tobacco/pdf/Guindon-Past,%20current-%20whole.pdf
242. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao Y, et al. Tobacco and cancer: recent epidemiological evidence. JNCI 2004;96:99–106. Available from: http://jnci.oxfordjournals.org/cgi/content/full/96/2/99
243. Warren C, Jones N, Eriksen M, Asma S, for the Global Tobacco Surveillance System GTSS collaborative group. Patterns of global tobacco use in young people and implications for future chronic disease burden in adults. Lancet 2006;367:749–53.
244. World Health Organization. The World Health Report 1999. Making a Difference. Geneva: WHO; 1999. Available from: http://www.who.int/whr/1999/en/index.html
245. Liu B, Peto R, Chen Z, Boreham J, Wu Y, Li J, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998;317:411–22. Available from: http://www.bmj.com/cgi/reprint/317/7170/1411
246. Siahpush M, Borland R. Trends in socioeconomic variations in smoking prevalence, 1997-2000. In: Research and Evaluation Committee, editor. Australia's National Tobacco Campaign. Evaluation Report Volume 3. Every cigarette is doing you damage. Canberra: Commonwealth of Australia; 2004. p149-59